Looking for investor for Pharmaceutical company in India

Dear Dr. Mallikarjuna,

I am working in Children’s hospital of Philadelphia as a senior research scientist in the department of Immunology and Psychiatry.I am investigating the pathophysiology of septic shock in terminally ill HIV/AIDS children and adolescent patients.

Basically I am a trauma surgeon in Bangladesh and I have completed my PhD from Japan in molecular pathology. When I worked at the department of Casualty Surgery, Dhaka Medical College Hospital, Dhaka, Bangladesh, I saw a large number of patients specially “burn, road traffic crush injuries or post operative ” developed infections very quickly even with very large dose of antibiotics. Many patients died within few days and doctors had no possible explanations for these kind of unfortunate loss of life.

Research on the cause of septic shock is still very controversial. A large group of researchers in the world believe that “endotoxin” from bacteria is the major cause of septic shock. On the basis of that concept, many pharmaceutical companies developed anti-endotoxins which were used in several septic shock clinical trials in developed countries like USA or Germany and Japan. Recently, in a clinical conference in USA, it was shown that despite of highly sophisticated antibiotic therapy with anti-endotoxin, none of the septic shock treatment strategy is working still now.

In my publications on the mechanism and treatment in animal models, I have shown that when 2M concentration goes down to 30% of its original concentration during septicemia, they die immediately. Bacterial proteases activate high-molecular weight kininogen (HK) and release bradykinin which causes severe hypotension. After bradykinin release from HK, it’s called HKa, which stimulates one of the blood cells (monocyte) and release cytokine (IL-1, TNFand IL-6) and chemokines (IL-8 and MCP-1). IL-1 and TNF comes back to monocyte, bind to the receptors (Mac-1)and give signal through signaling pathway p38, JNK, ERK and NFB and expresses tissue factor which is essential for blood coagulation. Bacterial proteases can cause all the phenomenon those occur in septic shock such as DIC, hypotension, tachycardia followed by bradycardia, low peripheral vascular resistance etc.

I like to investigate further on the pathophysiology of septic shock on a noble finding that major triggering molecule of septic shock is bacterial protease and not the traditional concept of endotoxin. The treatment of shock is possible by using a normal blood protein “alpha-2-macroglobulin” which could be a milestone of the development of septic shock treatment in human.

I can organize this work by collaborating hospitals located in Bangladesh if I have very minimum funding.
I am looking forward for your noble investment to a completely new concept of septic shock treatment that can be a noble approach to cure many septic shock people in the world.
Sincerely,
Mohammad M Khan, MBBS, PhD

Dear Mr.Mallikarjun,

I Appreciate your confidence and knowledge which you claim to have in the pharmaceutical field. i'am writing this mail from mysore(karnataka) . I'am planning to launch a pharma industry, initially a small scale which should yield a roaring turnover. If you feel you can contribute for the strong basement of the company, we can make a deal and you will be one of the partner of the firm.

Do you think you have something new? write me back , and i would be expecting a positive reply from you

Regards
Sucharith.M.S

hisir,

im avanish ....im totally new to pharma field , i would also like to set up a formulation plant . im ready to invest too. kindly get in touch with me . 09886692193 bangalore

Dear Sir,

we are interested in your project.Pl send me brief detail .

ANIL
anilendurance@yahoo.com

we are having diagnostic manufacturing unit willing to expand if you have an interest contact me: 9805250355 we are situated at 35 km from chandigarh baddi, himachal pradesh

I am looking for someone who could invest for a pharma company in West Bengal. I have an experience in the pharma market of 13 years. If you want to clarify any thing then you may please mail at banerjeern2003@yahoo.co.in

Dear Rakesh,

We are having one project and looking for invester who can invest 1 cr for the same and can join our group. We had finalised the facility in Aurangabad, Maharashtra which is a reputed destination to accuire good business in international & domestic market. We designed this project exclusively for Oncology Drugs and in future for ASVS. We had a good prospective designed business module to promote our products in international and domestic market and many more.

If your interested u can call me on +919820397514 or be in touch with me on vikas.khadtale@gmail.com

Thanks

Vikas Khadtale

dear sir,

we are looking for an investment of 2.5 crores to update our plant in himachel.
we are a private ltd company so for your investment you will be given shares of 10% in the company.

we have tablet capsule and ointment, investment for liquid & non beta lactum needed.
gmp compliant factory. 8 yrs excise free.

yes i will help you and give the suggestion,
now i am working with an mnc pharma company as 2nd line manager/having 11years exprnc.in pharma mkt,so i would like to disccuss with you
santosh mishra

Dear Sir,

Its an pleasure to introduce our self as a one of the leading Manufacturers and Exporters of plants and machineries for pharmaceuticals, cosmetics, chemicals, breweries and food industries.

We are pleased to supply you our Plants & Machineries as per your requirements.

We manufactures the following Plants and Machineries:-

A. Liquid Syrup Section:-(Turnkey Project)

1. Automatic liquid Syrup / Oral manufacturing plant
2. storage vessel
3. Automatic Bottling line(Bottle Washing, Bottle Filling, Bottle Capping Machine, Bottle labeling Machine)
4. Filter Press
5. Pressure vessel
6. Liquid mixing vessel

B. Ointment Section :-

1. Ointment/ cream / lotion / gel / toothpaste Manufacturing Plant
2. Ointment/ cream / lotion / gel / toothpaste mixing vessel

C. Tablet Section :-

1. Double cone blenders
2. V- Blender
3. Mass Mixer
4. Octagonal Blender

We have 5 Different Manufacturing Unit for different kind of plants and machineries with GMP(Good Manufacturing Practice) works.

Please send us your any requirement, we assure you to supply the quality machineries.

Thank you.

Regards,

Rakesh Panchal
(M) +91- 9428851947

(Sr. Mkt. Executive)

For: Sharp Pharma Machinery
----------------------------------------------------------------------------------------------------------------------------------------------
Sharp Pharma Machinery- An Iso 9001-2008 Certified Company
Regd. Office: "Sharp House" Plot No. 76, G.I.D.C., Kalol (N.G.) India-382721
Ph: +91(02764) 220525, 223086 Fax: +91 (02764) 223086
E-mail:- info@sharppharma com
Website: - wwwsharppharma dot com
----------------------------------------------------------------------------------------------------------------------------------------------

Dear Sir,
I can guide you to kick start Pharma Industry in the GCC area specifically in Dubai Or Bahrain.
Also I have ready market for Food Suppliments in this region on yearly contract basis.
You can write to me on my email: pramod(at)wincareuae(dot)com for further details.
Thanks & Regards
Pramoda G S
WINCARE DRUG LLC
DUBAI, UAE

Hi Ascar ,

can you send me your contact details and mail id to krishna.m369@gmail.com ..

are you interested in acquring pharma in india ? Please let me know asap

Thanks!
Krishna
krishna.m369@gmail.com
09866363916

a plant situated in himachal pradesh for sale.

department of tablet capsule & ointment for sale

production capacity

below 100mg tablets:1000000 /shift
capsules:4,00,000 capsules/shift
gel/ointment/cream:400 kg /shift
tubes:12000 tubesof aluminium & 12000 units of lami-tube

packing option:pvc blister machine double track :220 strips/min
aluminium strip machine: 4 track :200 strips/min
alu-alu pack: 3,oo,ooo tablets /capsule /shift

land:3000 sqmtr

wages min:3300 per month
RUNNING COST PER MONTH:3 LAKH TO 6 LAKH

MIN INVOICE RATE:
1000000 TABLETS X 3 SHIFTS X 24 WORKING DAYS X RS.10 PER TABLET INCLUDING PACKING=7200000
400000 CAPSULES X 3 SHIFTS X 24 WORKING DAYS X RS.40 PER CAPSULE INCL PACKING=11520000
10000 TUBES OF 10GM X 3 SHIFTS X 24 WORKING DAYS X RS 4 PER TUBE INCL PACKING=2880000
MIN TOTAL INVOICE CAPACITY:INR 21600000 /MONTH AT MIN 5% PROFIT MIN INR 1080000/MONTH

MAX INVOICE RATE:
1000000 TABLETS X 3 SHIFTS X 24 WORKING DAYS X RS 2 PER TABLET INCL PACKING=144000000
400000 CAPSULES X 3 SHIFTS X 24 WORKING DAYS X RS 3 PER CAPSULE INCL PACKING=86400000
10000 TUBES OF 10GM X 3 SHIFTS X 24 WORKING DAYS X RS 12 PER TUBE INCL PACKING=8640000
MAX TOTAL INVOICE CAPACITY:INR 239040000 /MONTH AT MIN 5% PROFIT MIN INR 11952000/MONTH

electricity:2.30/kvah

MAX ELE CONSUMPTION PER SHIFT 750 KVAH

asking rate:INR 7.5 crore

Dear Sir,
I am a pharma consultant from India and provide complete consultancy for new plant set up, purchase and sale of running units, third party manufacturing and also assist in marketing of pharma products. At present I have some good pharma plants for sale, which is a good deal and highly profitable. Apart from this I can also assist you in new pharma plant set up.
If interested please contact me at (+91)9997872012 / 9808107885 or email me and i can send you further details
Hoping for a positive response Inshallah
Regards
Arshad Nawaz
website: http://pharmaconsultant.webs.com

Please contact us on our mail ID organocure@gmail.com for further details. Thanks

Dear Sir/Madam,

I am pleased to utilize this opportunity in order to familiarize you with our company. Kleva is a leading Greek pharmaceutical company engaged in development, production and distribution of generic pharmaceutical products.
Our recently renovated factory in Athens-Greece, equipped with the latest technology machinery, has the manufacturing potentials for a wide range of pharmaceutical forms: tablets, capsules, liquids (syrups, suspensions, oral drops, topical, sterile eye and ear solutions) creams, gels, suppositories, nasal sprays and sterile injectibles following strictly the GMP's specifications and the WHO regulations.
Having considerable spare capacity we can offer contract – manufacturing services for the mentioned product forms.
Kleva is always striving for perfection in product quality in each stage of the manufacturing process. Furthermore, Kleva has an ISO 9001-2000 TUV AUSTRIA certification for the production and marketing of its products.
The excellent quality of our pharmaceuticals has led well-known European Houses to sign agreements for the production of their products in our manufacturing facilities. Furthermore our R&D department is currently developing some of the latest molecules available, such as Alendronate tabs 70mg.

Kleva has the potential to offer:
· High quality pharmaceuticals, at significantly low cost.
· A state-of-the art manufacturing plant including newly upgraded Class A (100) sterile units, available for contract manufacturing.
· «Know-how» of generic pharmaceuticals with complete registration files according to European Union guidelines.
· A constantly growing sales distribution network extending even outside Greece.

I shall be happy to provide additional information upon request, please accept my best regards.

Sincerely,

________________________
Dimitris Tsoublekas
B&D Manager
Tsoublekas@kleva.gr

Dear Sir,

I am intersted to dicuss possible cooperation and investment.
Please contact me on my cell number 010-1094225

Regards

Hani Rofael
Director, MBA

Dear
we are intrested in ur joint venture so plz kindly send us ur term and condition and brief detail of ur company

HI DEAR I M INTRESTED PLZ SEND ME DETAIL FOR J.V. / PARTENERSHIP..

REGARDS
GIRIJESH MISHRA
mbagirijeshmishra@gmail.com
+91-9044311628

Dear Sir,

I am Shahid from ranchi working in mumbai (B.Tech mech + MBA) want to be distributor/C&F in ranchi.

Please guide me with details.

Regards,
Shahid
shahidkhan042@gmail.com